1. Intra-arterially as well as intradermally administered adrenaline or noradrenaline produces a sweat response.
1. Intra-arterially as well as intradermally administered adrenaline or noradrenaline produces a sweat response.
2. The intensity of the intradermal response is always considerably less than that due to acetylcholine and the threshold of effective concentration is considerably greater than for acetylcholine. The glands also fail to respond to repeated small doses of intradermal catecholamine and to continued arterial catecholamine infusion.
3. Intradermal administration of a mixture of adrenaline and acetylcholine did not indicate that adrenaline potentiates the cholinergic response.
4. Intravenous infusions of 20 pg/min adrenaline neither produce a response by the resting glands nor affect the response of the active glands. Whilst intra-arterial infusions of high doses of adrenaline or noradrenaline produce a response by the resting glands they reduce the response of the active glands.
5. The results show that even though the catecholamine levels in a discharge of a phaeochromocytoma can be high enough to cause a discharge by resting glands, as the glands are likely to be secreting in response to neural stimulation, the effect of the secreted catecholamine would be inhibitory.
Human eccrine sweat glands respond to intradermal adrenaline and noradrenaline, and this response is blocked by a-receptor blocking agents such as tolazoline hydrochloride (Chalmers & Keele, 1951) . Although there would appear to be specific adrenergic receptors in these glands the existence of an adrenergic component in their innervation could not be established (Chalmers & Keele, 1951) . These receptors could conceivably respond to circulating catecholamines released by the adrenal medulla, particularly during the secretion of excessive amounts of catecholamines as during the discharge of a phaeochromocytoma when sweating is a prominent feature. This possibility is, however, unlikely in view of the finding by Prout & Wardell (1969) Kuno (1965) has claimed that the action of adrenaline is to potentiate the sudorific action of acetylcholine, and has postulated that circulating adrenaline will potentiate the nervous response.
Using a rapid and sensitive method for monitoring the sweat response we have, therefore, re-examined the possible role of circulating catecholamines in the control of the human eccrine sweat glands.
METHODS
Sweat secretion was measured in glands on the flexor surface of the forearm using a ventilated capsule in conjunction with an infra-red analyser (Foster & Weiner, 1967) .
The effects of catecholamines were studied on (1) resting glands, (2) thermally stimulated glands, and (3) glands stimulated by acetylcholine. Thermal sweating was induced either by placing the subject's feet in hot water or by putting the subject in a suit ventilated by warm air. The body temperature was measured by placing a thermistor in the external auditory meatus.
Catecholamines, acetylcholine, and blocking agents were given by intradermal injection through an indwelling needle (Foster & Weiner, 1967) . All solutions for intradermal injection were at 37°, since the acetylcholine response is optimal at this temperature. Catecholamines were also administered parenterally-intravenously by infusion into the cubital vein of the opposite forearm, and intra-arterially into the brachial artery leading directly to the glands. Dilutions of acetylcholine chloride, L-noradrenaline bitartrate, adrenaline, isoprenaline hydrochloride, and phentolamine mesylate were made with physiological saline immediately before each experiment. Ascorbic acid was added to the solutions of catecholamine to prevent oxidation (Gad dum, Peart & Vogt, 1949) . All subjects were healthy adult volunteers and were fully informed of the nature and purpose of the study.
RESULTS

Effect of intradermal administration of catecholamines
As with acetylcholine ( Fig. la) there was a rapid onset of the sweat response following the intradermal injection ofO'l-lOj!g adrenaline or noradrenaline in 0·1 ml physiological saline. There were no obvious differences between the adrenaline and noradrenaline responses. Results obtained from five subjects showed that the maximum height of the catecholamine response was always much lower than that due to the same dose of acetylcholine in a given subject. Fig. 1 shows a comparison between these responses in one of these subjects. Results obtained from three subjects also showed that no response occurred with 10-2 j!g/O'l ml adrenaline or noradrenaline. These three subjects always responded to doses of acetylcholine as low as 10-2 • 5 j!g/O'l ml. The decline in the response from its peak was, however, usually much slower than that due to a similar dose of acetylcholine (Fig. la) .
On repeated intradermal administration of catecholamine (0,1 and 5 j!g/O·l ml) the glandular response invariably declined. A similar failure occurs in the eat's pad (Foster, 1968) . The response to a second dose of catecholamine was markedly decreased compared to the first dose, and subsequent doses showed further decreases with, in some cases, eventual failure to respond ( Fig. 2 ). This failure still occurred when subjects had been heated (active sweating having previously been blocked by atropine). In one subject, however, during very hot weather, it was possible to obtain repeated adrenaline responses, but the glands eventually failed to secrete.
The possibility of a potentiating effect of adrenaline on the acetylcholine response was examined. In these experiments the effects due to a given dose of acetylcholine were observed first; the adrenaline-acetylcholine mixture was then administered at the same site. Although the response due to a submaximally active dose of acetylcholine (10-2 p.g/O·l ml) was increased by above threshold doses of adrenaline it was reduced by subthreshold doses of adrenaline (10-2 and 10-3 p.g/O·l ml), Increased responses were either slightly greater or slightly less than that due to a simple summation of the separate acetylcholine and adrenaline responses (Table 1) . When the dose of acetylcholine produced a maximal rate of secretion, the rate was not increased any further even by large doses ofadrenaline (Table I ). The decline in the response due to the acetylcholine-adrenaline mixture tended to be slower than that due to the acetylcholine alone. These results do not support Kuno's hypothesis.
The loss of responsiveness of the glands to repeated doses of catecholamines did not affect the response of the glands to a subsequent administration of acetylcholine provided this was at a level (10-1 J-lgjO'1 ml) capable of producing a maximal response ( Table 2 ). The previous administration of adrenaline, even at a subthreshold dose (10-2 J-lgjO'1 ml) did however reduce the response to acetylcholine given in a dose of submaximal potency. Effect ofparenteral infusions of catecholamines on resting glands Intravenous infusions. The intravenous infusion of 20 p,gjmin adrenaline for periods of 20 min into one unheated or four heated subjects had no effect on sweat production. In the heated subjects a high rate of thermal sweating was first induced, and then just before the start of the adrenaline infusion the thermal response was completely blocked by the intradermal injection of 20 J-lg atropine. The intradermal injection of adrenaline after the cessation of the infusion showed, however, that the glands were still responsive to adrenaline.
Intra-arterial infusions. The intra-arterial infusion of adrenaline in doses ranging from 4 to 10J-lgjmin in five unheated subjects produced a definite response. This response was not blocked by 20 J-lg atropine administered just before the start of the infusion (Fig. 3a) or during the infusion (Fig. 3b) . The response was, however, blocked by 20 p,g phentolamine (Fig. 3b) . The infusion produced intense pallor in the whole of the arm peripheral to the infusion site. A larger sweat response was obtained by keeping the arm warm with lamps.
The response failed to be maintained with continued infusion of adrenaline (Fig. 3a) ; with a subsequent infusion of adrenaline little or no response occurred.
Five J-lgjmin noradrenaline in one subject also produced a response when infused intraarterially. The arterial infusion of 2 J-lgjmin of isoprenaline in one subject on the other hand was not effective.
Effect ofparenteral infusion of catecholamines on active glands
Intravenous infusions. During heating of the subject, the intravenous infusion of 20 J-lgjmin adrenaline whilst the glands were moderately active and still capable of an increased response (ear temperature about 37,2°) did not enhance the thermal response (Fig. 4) . Intra-arterial infusions. The intra-arterial infusion of 5 flgfmin adrenaline during thermal sweating caused the response to decrease (Fig. 5) . The arterial infusion of2 flgfmin isoprenaline in one subject did not, however, affect the response.
DISCUSSION
Acetylcholine and catecholamines compared
Even though noradrenaline and adrenaline can stimulate the glands either by intradermal injection or intra-arterial infusion, the sweat output is small compared to that due to intradermal acetylcholine. The amplitude of the response to intradermal catecholamine was always considerably less and the concentration of the effective threshold dose higher than that for acetylcholine (Fig. lb) . These results contrast sharply with those obtained by Chalmers & Keele (1951) , who found no difference between the adrenaline and acetylcholine thresholds. It is very likely that their methods did not permit the detection of the more ephemeral responses due to very low doses of acetylcholine. The poorer response to adrenaline could be due to concomitant cutaneous vasoconstriction depriving the gland of its oxygen supply (van Heyningen & Weiner, 1952; Hubbard & Weiner, 1969) .
Acetylcholine and adrenaline differ also in their effects when administered repeatedly. Whilst the sweat glands fail to respond to repeated very high doses of intradermal acetylcholine (2-5 mgjO'05 ml) or methylcholine (400Jlg to 1 mgjO·05 ml) (Collins, Sargent & Weiner, 1959) they will respond to repeated small doses (1-10 JlgjO·1 ml) with little or no diminution in output. However, repeated small doses of intradermal catecholamine bring about a rapid failure of response as does continued arterial infusion of adrenaline. Collins et al. (1959) ascribed the reduction in sweat gland activity with repeated high doses of cholinomimetics to desensitization of the receptors. Whether this accounts for the fall-off in output on repeated catecholamine administration has not been explained. Thecausemay, however, be in the intense vasoconstriction induced by repeated injection of catecholamine rendering the glands progressively more ischaemic. Since acetylcholine has a local vasodilator action this would explain the finding that the response to maximal doses of acetylcholine is not affected by the previous injection of catecholamine. Nevertheless, a reduction in the response due to submaximal doses of acetylcholine occurs with the simultaneous or previous injection of subthreshold doses of catecholamine.
Role of circulating catecholamines
No evidence was obtained indicating that adrenaline can potentiate the cholinergic response as postulated by Kuno (1965) . The injection of mixtures of near maximally active doses of catecholamine and submaximally active doses of acetylcholine produced responses greater than those due to acetylcholine alone, but the response for the mixture merely approximated to the summation of the separate responses due to the two drugs. Nor was a maximal acetylcholine response increased by adrenaline. In fact, submaximal acetylcholine responses were reduced by subthreshold doses of catecholamine administered simultaneously or before the acetylcholine.
We may now examine the conditions under which the sweat glands might be stimulated by circulating catecholamine in the intact organism. From our results this would require the circulation of a very high level of catecholamine acting on glands which are not at the same time undergoing nervous stimulation. When glands are thermally stimulated these high levels of catecholamine have in fact an inhibitory effect (Fig. 5) .
Sweat secretion did not occur with the intravenous infusion of 20 Jlgjmin adrenaline, which would produce a concentration of approximately 2 Jlgjl adrenaline in the peripheral venous blood (Vendsalu, 1960) . As normal resting concentrations of catecholamines in the venous plasma are only of the order of 0·4 Jlgjlitre (price & Price, 1957; Vendsa1u, 1960) even the 4-6-fold increases in the catecholamine level occurring in severe and prolonged exercise (Haggendal, 1963) are unlikely to induce sweating. Furthermore, the thermal sweat response was not increased by the intravenous infusion of 20 Jlgjmin adrenaline (Fig. 4) and so the sweating induced by neural mechanisms during exercise is unlikely to be enhanced by secreted catecholamine as suggested by Kuno (1965) .
High plasma concentrations of catecholamines are produced in asphyxia; the output of catecholamines from the adrenal medulla can increase in the cat to 1 J1g kg-1 min-1 (von Euler & Folkow, 1953) or 1·3 J1g kg-1 min"? (Celander, 1954) . When the asphyxia is so severe that artificial respiration must be applied this rises to 2-2'5 J1g kg-1 min -1 (Celander, 1954) . A level of 1-1'3 J1g kg-1 min"! is equivalent to an output of 70-90 J1g/min for a 70 kg man. A hot sweating subject has a forearm skin blood flow five times the resting level (Barcroft & Hamilton, 1948) , and the high catecholamine levels occurring during asphyxia are likely to reduce the skin blood flow (Celander, 1954 ). An infusion of 20 J1g/min in a hot sweating subject should be as effective in its action on the glands as an output of at least 100 J1g/min in an asphyxiated individual, but this dose did not stimulate the glands.
In our experiments doses of adrenaline and noradrenaline (4-10 J1g/min) were found to be definitely effective in inducing a response by the resting glands when infused arterially. Resting forearm blood flow is of the order of 1-3 mll00 g tissue"? min-1 (Hellon, Lind & Weiner, 1956) , and as the forearm volumes are approximately 1·5 I, the concentration of catecholamine reaching the glands would in these experiments have been of the order of 90-270 J1g/l. As the level of catecholamine in the plasma during a phaeochromocytoma crisis can be as high as 98 J1g/1 (Lund, 1952) or 85 J1g/1 (Hermann & Mornex, 1964) it seems possible that under such conditions a sweat secretion due to direct stimulation of sweat gland receptors might be induced by endogenous catecholamine. These levels of catecholamine, however, reduce the response of glands which are already active (Fig. 5) . Our results show, therefore, that catecholamine.levels in phaeochromocytoma crises may in some patient's be high enough directly to stimulate glands which are in the resting state. However, probably due to an elevated body temperature (Pickering, 1955) , the glands are likely to be under neural stimulation (Prout & Wardell, 1969) , and the vasoconstrictor effect of the catecholamine would reduce rather than elevate the response. Many of the symptoms occurring in patients with hyperthyroidism closely resemble the effects of overactivity of the sympathetic nervous system, and although the precise role of catecholamines in determining the various manifestations of sympathetic overactivity (such as tachycardia, tremor and sweating) in thyrotoxicosis is not fully understood, it is unlikely that the sweat glands are responding to catecholamines released by the adrenal medulla as the sweating is blocked by f3-receptor blocking agents such as propranolol.
